Clinical Trial Update: Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy [Phase 1, Phase 2]

View source ↗

Summary

This document reports completion and results posting for a Phase 1/2 study evaluating leflunomide as a treatment for severe COVID-19 in patients with concurrent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-07-03